Back
Pharvaris NV Vs. ProQR Therapeutics NV Industry Stock Comparison
Buy
57
PHVS
Pharvaris NV
Last Price:
23.17
Seasonality Move:
27.47%
Buy
61
PRQR
ProQR Therapeutics NV
Last Price:
2.02
Seasonality Move:
0.03%
Buy
57
Pharvaris NV (PHVS)
is a Buy
Is Pharvaris NV a Buy, Sell or Hold?
- The current Pharvaris NV [PHVS] share price is $22.60. The Score for PHVS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PHVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
- The current ProQR Therapeutics NV [PRQR] share price is $2.01. The Score for PRQR is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- PRQR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHVS Stock Price Chart
What is Pharvaris NV's stock price today?
-
The Pharvaris NV share price today is $22.60
The current trend is relatively stagnant and PHVS is experiencing selling pressure, which indicates risk of future bearish movement.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRQR is experiencing slight selling pressure.
PHVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 49.49 | Sell |
| Chaikin Money Flow: | -45752 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.62 - 23.48) | Buy |
| Bollinger Bands (100): | (22.59 - 28.29) | Sell |
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 46.36 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.94 - 2.2) | Sell |
| Bollinger Bands (100): | (1.93 - 2.29) | Sell |
PHVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.24 | Sell |
| 20-day SMA: | 22 | Buy |
| 50-day SMA: | 23.19 | Sell |
| 200-day SMA: | 22.11 | Buy |
| 8-day EMA: | 23.04 | Sell |
| 20-day EMA: | 22.59 | Buy |
| 50-day EMA: | 23.27 | Sell |
| 200-day EMA: | 21.51 | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.98 | Buy |
| 20-day SMA: | 2.05 | Sell |
| 50-day SMA: | 2.13 | Sell |
| 200-day SMA: | 1.79 | Buy |
| 8-day EMA: | 1.99 | Buy |
| 20-day EMA: | 2.04 | Sell |
| 50-day EMA: | 2.09 | Sell |
| 200-day EMA: | 1.96 | Buy |
Pharvaris NV Earnings Growth & PHVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.26 per share.
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and a decrease next year of $0.25 per share.
Pharvaris NV Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProQR Therapeutics NV Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||